Drug Shortage Report for APO-ALENDRONATE

Last updated on 2017-12-31 History
Report ID 18512
Drug Identification Number 02248730
Brand name APO-ALENDRONATE
Common or Proper name ALENDRONATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4 BLS
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-04
Estimated end date 2017-12-29
Actual end date 2017-12-29
Shortage status Resolved
Updated date 2017-12-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2017-12-31 French Compare
v19 2017-12-31 English Compare
v18 2017-12-19 French Compare
v17 2017-12-19 English Compare
v16 2017-11-20 French Compare
v15 2017-11-20 English Compare
v14 2017-11-15 French Compare
v13 2017-11-15 English Compare
v12 2017-11-13 French Compare
v11 2017-11-13 English Compare
v10 2017-10-31 French Compare
v9 2017-10-31 English Compare
v8 2017-10-10 French Compare
v7 2017-10-10 English Compare
v6 2017-09-22 French Compare
v5 2017-09-22 English Compare
v4 2017-09-03 French Compare
v3 2017-09-03 English Compare
v2 2017-08-08 French Compare
v1 2017-08-08 English Compare

Showing 1 to 20 of 20